HomeHRMY • NASDAQ
Harmony Biosciences Holdings Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 201.27M | 19.51% |
Operating expense | 91.13M | 7.13% |
Net income | 49.48M | 85.95% |
Net profit margin | 24.58 | 55.57% |
Earnings per share | 1.08 | 47.95% |
EBITDA | 61.70M | 33.19% |
Effective tax rate | 11.90% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 467.19M | 32.18% |
Total assets | 999.20M | 23.14% |
Total liabilities | 340.05M | -1.28% |
Total equity | 659.16M | — |
Shares outstanding | 57.35M | — |
Price to book | 2.91 | — |
Return on assets | 14.46% | — |
Return on capital | 17.17% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 49.48M | 85.95% |
Cash from operations | 75.56M | -1.44% |
Cash from investing | -7.19M | 80.07% |
Cash from financing | -2.74M | 94.88% |
Net change in cash | 65.63M | 607.89% |
Free cash flow | 59.31M | -29.02% |
Previous close
$33.60
Day range
$32.92 - $34.00
Year range
$28.14 - $41.61
Market cap
1.89B USD
Avg Volume
669.51K
P/E ratio
13.11
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Website
Employees
268
